| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Co-chief Executive Officer
1 company
Klee Justin B. serves as a Co-chief Executive Officer at AMLX. Across recent SEC filings that breaks down to 0 buys and 20 sells. Those positions are worth an estimated $119.8M at current prices.
Historically, Klee Justin B.'s trades have earned a middling insider score of 60/100 across 11 rated trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -21.8%.
The biggest single holding is AMLX (~$119.8M) as Co-chief Executive Officer. The recent filings there lean toward selling, a net 431,068 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 30,464 | $32.18 | $980,263.27 | -0.8% | - | - | |
| Mar 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 29,282 | $14.47 | $423,760.32 | -0.9% | -8.0% | - | |
| Feb 2, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 15,500 | $14.69 | $227,617.50 | -0.5% | +12.2% | - | |
| Jan 16, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sale+OE | 138,188 | $13.59 | $1,877,569.83 | -3.9% | +24.0% | - | |
| Jan 6, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 7,715 | $11.09 | $85,589.44 | -0.2% | +39.0% | - | |
| Sep 30, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 29,975 | $14.38 | $430,952.12 | -0.9% | -10.3% | +114.1% | |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 21,490 | $3.46 | $74,454.25 | -0.6% | +81.1% | +292.7% | |
| Mar 3, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 4,595 | $3.15 | $14,483.44 | -0.1% | +70.0% | +370.3% | |
| Feb 3, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 11,855 | $3.47 | $41,103.66 | -0.4% | +50.6% | +323.7% | |
| Jan 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | Co-chief Executive Officer | Sell | 7,471 | $4.04 | $30,201.52 | -0.2% | -11.7% | +190.3% |